Managing dyspepsia: what do we know and what do we need to know?

Area of Science:

• Gastroenterology
• Internal Medicine
• Clinical Practice Guidelines

Background:

• Helicobacter pylori is now recognized as a key factor in peptic ulcer disease pathogenesis.
• This paradigm shift necessitates re-evaluating dyspepsia management strategies.

Purpose of the Study:

• To critically assess current knowledge on dyspepsia and its clinical management.
• To explore the integration of Helicobacter pylori testing into dyspepsia care pathways.

Main Methods:

• Systematic literature review of MEDLINE-indexed articles and bibliographies.
• Analysis of studies on dyspepsia prevalence, endoscopic findings, and management strategies.

Main Results:

• Strategies combining H. pylori serology with clinical factors can identify organic disease, potentially reducing endoscopies.
• Computerized models suggest H. pylori-guided empiric therapy may be cost-effective.
• Data on symptom outcomes and the impact of these strategies in primary care are lacking.

Conclusions:

• Current evidence is insufficient to guide the integration of H. pylori testing and antimicrobial therapies in primary care for dyspepsia.
• A randomized controlled trial is urgently needed to evaluate alternative management strategies.
• Development of valid instruments for measuring dyspepsia symptoms is crucial for future research.